From confluent human iPS cells to self-forming neural retina and retinal pigmented epithelium

Progress in retinal-cell therapy derived from human pluripotent stem cells currently faces technical challenges that require the development of easy and standardized protocols. Here, we developed a simple retinal differentiation method, based on confluent human induced pluripotent stem cells (hiPSC)...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 111; no. 23; pp. 8518 - 8523
Main Authors Reichman, Sacha, Terray, Angélique, Slembrouck, Amélie, Nanteau, Céline, Orieux, Gaël, Habeler, Walter, Nandrot, Emeline F., Sahel, José-Alain, Monville, Christelle, Goureau, Olivier
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 10.06.2014
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Progress in retinal-cell therapy derived from human pluripotent stem cells currently faces technical challenges that require the development of easy and standardized protocols. Here, we developed a simple retinal differentiation method, based on confluent human induced pluripotent stem cells (hiPSC), bypassing embryoid body formation and the use of exogenous molecules, coating, or Matrigel. In 2 wk, we generated both retinal pigmented epithelial cells and self-forming neural retina (NR)-like structures containing retinal progenitor cells (RPCs). We report sequential differentiation from RPCs to the seven neuroretinal cell types in maturated NR-like structures as floating cultures, thereby revealing the multipotency of RPCs generated from integration-free hiPSCs. Furthermore, Notch pathway inhibition boosted the generation of photoreceptor precursor cells, crucial in establishing cell therapy strategies. This innovative process proposed here provides a readily efficient and scalable approach to produce retinal cells for regenerative medicine and for drug-screening purposes, as well as an in vitro model of human retinal development and disease.
Bibliography:http://dx.doi.org/10.1073/pnas.1324212111
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited* by Nicole M. Le Douarin, Centre National de La Recherche Scientifique, Gif-sur-Yvette, France, and approved May 2, 2014 (received for review December 31, 2013)
Author contributions: S.R., J.-A.S., and O.G. designed research; S.R., A.T., A.S., C.N., and O.G. performed research; G.O., W.H., E.F.N., and C.M. contributed new reagents/analytic tools; S.R., A.T., C.M., and O.G. analyzed data; and S.R. and O.G. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1324212111